Drug: VINCRISTINE SULFATE. Injury: Hyperbilirubinaemia Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125869531 | VINCRISTINE SULFATE. | Hyperbilirubinaemia | 10.92 YR | M | 46 KG | 20160722 | US | |
125972611 | VINCRISTINE SULFATE. | Hyperbilirubinaemia | 41.37 YR | F | 148 KG | 20160726 | US | |
126063601 | VINCRISTINE SULFATE. | Hyperbilirubinaemia | 20.51 YR | F | 51 KG | 20160728 | US | |
126476381 | VINCRISTINE SULFATE. | Hyperbilirubinaemia | 41.37 YR | F | 148 KG | 20160811 | US | |
127452841 | VINCRISTINE SULFATE. | Hyperbilirubinaemia | FDA-CTU | 1.83 YR | M | 26 KG | 20160914 | US |
127755151 | VINCRISTINE SULFATE. | Hyperbilirubinaemia | FDA-CTU | 14.19 YR | M | 61 KG | 20160920 | US |
Total Records: 6 Number of Pages: 1